BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7034096)

  • 1. Reduced susceptibility of nonenzymatically glucosylated glomerular basement membrane to proteases: is thickening of diabetic glomerular basement membranes due to reduced proteolytic degradation?
    Lubec G; Pollak A
    Ren Physiol; 1980; 3(1-6):4-8. PubMed ID: 7034096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic degradation of the glomerular basement membrane and immunochemical characterization of split products.
    Lubec G; Förster O; Coradello H; Maxa E; Pollak A
    Ren Physiol; 1980; 3(1-6):126-32. PubMed ID: 7034090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation of glomerular basement membrane in Type 1 (insulin-dependent) diabetic children.
    Schober E; Pollak A; Coradello H; Lubec G
    Diabetologia; 1982 Dec; 23(6):485-7. PubMed ID: 7152160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of human glomerular basement membrane in diabetes mellitus.
    Schleicher E; Wieland OH
    J Clin Chem Clin Biochem; 1984 Mar; 22(3):223-7. PubMed ID: 6726120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of glomerular basement membrane in diabetes. II. Proteolytic activity of diabetic and nondiabetic glomeruli.
    Leber R; Knecht R; Hasslacher C
    Res Exp Med (Berl); 1987; 187(5):347-52. PubMed ID: 3324240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reduced susceptibility of nonenzymatically glucosylated peptides against proteolytic cleavage (author's transl)].
    Lubec G; Pollak A; Coradello H; Leban H
    Padiatr Padol; 1982; 17(2):473-8. PubMed ID: 6124924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of glomerular basement membrane in diabetes. I. Susceptibility of diabetic and nondiabetic basement membrane to proteolytic degradation of isolated glomeruli.
    Knecht R; Leber R; Hasslacher C
    Res Exp Med (Berl); 1987; 187(5):323-8. PubMed ID: 3324239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic reversibility of nonenzymatic glycosylation of the glomerular basement membrane. Is the diabetic glomerulopathy principally reversible?
    Lubec G; Vycudilik W; Coradello H; Pollak A
    Nephron; 1983; 33(1):26-8. PubMed ID: 6835451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonenzymatic glycation of basement membranes from human glomeruli and bovine sources. Effect of diabetes and age.
    Garlick RL; Bunn HF; Spiro RG
    Diabetes; 1988 Aug; 37(8):1144-50. PubMed ID: 3134265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo biosynthesis and turnover of glomerular basement membrane in diabetic rats.
    Cohen MP; Surma ML; Wu VY
    Am J Physiol; 1982 Apr; 242(4):F385-9. PubMed ID: 7039363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on collagen metabolism in rats. II. Turnover and amino acid composition of the collagen of glomerular basement membrane in diabetes mellitus.
    Romen W; Lange HW; Hempel K; Heck T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 36(2-3):313-20. PubMed ID: 6116343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential transport of non-enzymatically glucosylated ferritin across the kidney glomerulus.
    Williams SK; Siegal RK
    Kidney Int; 1985 Aug; 28(2):146-52. PubMed ID: 3834226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
    van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
    Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic microangiopathy. I. Current status of the chemistry and metabolism of the glomerular basement membrane.
    Reddi AS
    Metabolism; 1978 Jan; 27(1):107-24. PubMed ID: 339033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulopathy in rats with streptozotocin diabetes. Accumulation of glomerular basement membrane analogous to human diabetic nephropathy.
    Cohen MP; Klein CV
    J Exp Med; 1979 Mar; 149(3):623-31. PubMed ID: 155128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical properties of human glomerular basement membrane in normal and diabetic kidneys.
    Kefalides NA
    J Clin Invest; 1974 Feb; 53(2):403-7. PubMed ID: 11344553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(35)S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes.
    Cohen MP; Surma ML
    J Lab Clin Med; 1981 Nov; 98(5):715-22. PubMed ID: 7028893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition of basement membrane in vitro by normal and diabetic rat renal glomeruli.
    Cohen MP; Dasmahapatra A; Wu VY
    Nephron; 1981; 27(3):146-51. PubMed ID: 7219644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical differences in human glomerular basement membrane related to diabetes and age.
    De Bats A; Rhodes EL; Gordon AH; Parke DV
    Ann Clin Biochem; 1982 Jan; 19(Pt 1):17-21. PubMed ID: 7065629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonenzymatic glycosylation of glomerular basement membrane.
    Cohen MP; Urdanivia E; Wu VY
    Ren Physiol; 1981; 4(2-3):90-5. PubMed ID: 7302366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.